rs369033909
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001127222.2(CACNA1A):c.5133+10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000306 in 1,606,702 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00032 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 1 hom. )
Consequence
CACNA1A
NM_001127222.2 intron
NM_001127222.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.65
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 19-13235199-C-T is Benign according to our data. Variant chr19-13235199-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 283174.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=1}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000315 (48/152260) while in subpopulation AMR AF= 0.0019 (29/15300). AF 95% confidence interval is 0.00136. There are 1 homozygotes in gnomad4. There are 23 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 48 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1A | NM_001127222.2 | c.5133+10G>A | intron_variant | ENST00000360228.11 | NP_001120694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.5133+10G>A | intron_variant | 1 | NM_001127222.2 | ENSP00000353362.5 | ||||
CACNA1A | ENST00000638029.1 | c.5151+10G>A | intron_variant | 5 | ENSP00000489829.1 | |||||
CACNA1A | ENST00000573710.7 | c.5139+10G>A | intron_variant | 5 | ENSP00000460092.3 | |||||
CACNA1A | ENST00000635727.1 | c.5136+10G>A | intron_variant | 5 | ENSP00000490001.1 | |||||
CACNA1A | ENST00000637769.1 | c.5136+10G>A | intron_variant | 1 | ENSP00000489778.1 | |||||
CACNA1A | ENST00000636012.1 | c.5136+10G>A | intron_variant | 5 | ENSP00000490223.1 | |||||
CACNA1A | ENST00000637736.1 | c.4995+10G>A | intron_variant | 5 | ENSP00000489861.1 | |||||
CACNA1A | ENST00000636389.1 | c.5136+10G>A | intron_variant | 5 | ENSP00000489992.1 | |||||
CACNA1A | ENST00000637432.1 | c.5151+10G>A | intron_variant | 5 | ENSP00000490617.1 | |||||
CACNA1A | ENST00000636549.1 | c.5142+10G>A | intron_variant | 5 | ENSP00000490578.1 | |||||
CACNA1A | ENST00000637927.1 | c.5139+10G>A | intron_variant | 5 | ENSP00000489715.1 | |||||
CACNA1A | ENST00000635895.1 | c.5136+10G>A | intron_variant | 5 | ENSP00000490323.1 | |||||
CACNA1A | ENST00000638009.2 | c.5136+10G>A | intron_variant | 1 | ENSP00000489913.1 | |||||
CACNA1A | ENST00000637276.1 | c.5136+10G>A | intron_variant | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152142Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
48
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000560 AC: 132AN: 235706Hom.: 0 AF XY: 0.000438 AC XY: 56AN XY: 127824
GnomAD3 exomes
AF:
AC:
132
AN:
235706
Hom.:
AF XY:
AC XY:
56
AN XY:
127824
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000305 AC: 444AN: 1454442Hom.: 1 Cov.: 31 AF XY: 0.000277 AC XY: 200AN XY: 723048
GnomAD4 exome
AF:
AC:
444
AN:
1454442
Hom.:
Cov.:
31
AF XY:
AC XY:
200
AN XY:
723048
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000315 AC: 48AN: 152260Hom.: 1 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74440
GnomAD4 genome
AF:
AC:
48
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
23
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 24, 2017 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 04, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at